Ganessan Kichenadasse

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Secondary Somatic Mutations Restoring <i>RAD51C</i> and <i>RAD51D</i> Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Olga Kondrashova, Minh Nguyen, Kristy Shield‐Artin et al. · Cancer Discovery · 2017 · 417 citations · Full text

Medicine, Genetics, Oncology +17

Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni et al. · JAMA Oncology · 2019 · 347 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift

Ashley M. Hopkins, Jessica M. Logan, Ganessan Kichenadasse et al. · JNCI Cancer Spectrum · 2023 · 262 citations · Full text

Computing, Biomedical Informatics, Health Informatics +15

Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies

Gargi Patel, Kunal Jain, Rajiv Kumar et al. · Supportive Care in Cancer · 2013 · 148 citations

Medicine, Oncology, Surgery +3